Latest News

Inamul Kabir, PhD, was selected for a Career Development Award (2022-2025) from the American Heart Association.

New insights into the molecular and cellular development of a rare heart defect.

A Yale-led study provides new insights into the molecular and cellular development of supravalvular aortic stenosis (SVAS).

A Yale-led study provides new insights into the molecular and cellular development of idiopathic pulmonary fibrosis (IPF), a lethal lung disease that has been diagnosed with increased frequency.

Daniel Greif, MD, has been appointed as the vice chair (2021-2022) and chairman-elect (2022-2023) of the Scientific Committee for Sarnoff Cardiovascular Research Foundation.

There have been 121 faculty appointments and promotions across 11 sections in the Department of Internal Medicine since September of 2018.

The American Heart Association has awarded to Daniel Greif, MD a grant to study the mechanisms of reverse vascular remodeling in pulmonary hypertension.

In a new study, Yale researchers investigate how plaque cells develop at the molecular level, and their findings could help produce targeted treatments for the disease.

Pulmonary hypertension is a type of high blood pressure that affects blood vessels in the lungs. Once diagnosed, patients have limited treatment options, and many do not live beyond seven years. In a new study, scientists in the Yale Cardiovascular Research Center have gained new insight into the development of the disease that could lead to new therapies.